TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines

被引:289
作者
Hastings, William D. [1 ]
Anderson, David E. [1 ]
Kassam, Nasim [1 ]
Koguchi, Ken [1 ]
Greenfield, Edward A. [1 ]
Kent, Sally C. [1 ]
Zheng, Xin Xiao [2 ,3 ]
Strom, Terry B. [2 ,3 ]
Hafler, David A. [1 ]
Kuchroo, Vijay K. [1 ]
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Beth Israel & Deaconess Hosp, Div Immunol, Boston, MA USA
[3] Harvard Univ, Sch Med, Beth Israel & Deaconess Hosp, Transplant Res Ctr, Boston, MA USA
基金
美国国家卫生研究院;
关键词
Cell activation; Human; Immunosuppression; T cells; TUMOR-INFILTRATING LYMPHOCYTES; GROWTH-FACTOR-BETA; MULTIPLE-SCLEROSIS; T(H)17 CELLS; RESPONSES; INDUCTION; IMMUNITY; DIFFERENTIATION; AUTOIMMUNE; TOLERANCE;
D O I
10.1002/eji.200939274
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TIM-3 is a molecule selectively expressed on a subset of murine IFN-gamma-secreting T helper 1 (Th1) cells but not Th2 cells, and regulates Th1 immunity and tolerance in vivo. At this time little is known about the role of TIM-3 on human T cells. To determine if TIM-3 similarly identifies and regulates Th1 cells in humans, we generated a panel of mAb specific for human TIM-3. We report that TIM-3 is expressed by a subset of activated CD4(+) cells, and that anti-CD3/anti-CD28 stimulation increases both the level of expression as well as the number of TIM-3(+) T cells. We also find that TIM-3 is expressed at high levels on in vitro polarized Th1 cells, and is expressed at lower levels on Th17 cells. In addition, human CD4(+) T cells secreted elevated levels of IFN-gamma, IL-17, IL-2, and IL-6, but not IL-10, IL-4, or TNF-alpha, when stimulated with anti-CD3/anti-CD28 in the presence of TIM-3-specific, putative antagonistic antibodies. This was not mediated by differences in proliferation or cell death, but rather by induction of cytokines at the transcriptional level. These results suggest that TIM-3 is a negative regulator of human T cells and regulates Th1 and Th17 cytokine secretion.
引用
收藏
页码:2492 / 2501
页数:10
相关论文
共 29 条
[11]   CHARACTERIZATION OF AUTOLOGOUS TUMOR-SPECIFIC T-HELPER-2 CELLS IN TUMOR-INFILTRATING LYMPHOCYTES FROM A PATIENT WITH METASTATIC MELANOMA [J].
KHARKEVITCH, DD ;
SEITO, D ;
BALCH, GC ;
MAEDA, T ;
BALCH, CM ;
ITOH, K .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (03) :317-323
[12]   Dysregulated T cell expression of TIM3 in multiple sclerosis [J].
Koguchi, Ken ;
Anderson, David E. ;
Yang, Li ;
O'Connor, Kevin C. ;
Kuchroo, Vijay K. ;
Hafler, David A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (06) :1413-1418
[13]   The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt [J].
Manel, Nicolas ;
Unutmaz, Derya ;
Littman, Dan R. .
NATURE IMMUNOLOGY, 2008, 9 (06) :641-649
[14]   TH1-TH2 PARADIGM - INSIGHTS FROM LEPROSY [J].
MODLIN, RL .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (06) :828-832
[15]   Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease [J].
Monney, L ;
Sabatos, CA ;
Gaglia, JL ;
Ryu, A ;
Waldner, H ;
Chernova, T ;
Manning, S ;
Greenfield, EA ;
Coyle, AJ ;
Sobel, RA ;
Freeman, GJ ;
Kuchroo, VK .
NATURE, 2002, 415 (6871) :536-541
[16]  
MOSMAN TR, 1986, J IMMUNOL, V7, P2348
[17]   Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions [J].
Nagahara, Keiko ;
Arikawa, Tomohiro ;
Oomizu, Souichi ;
Kontani, Keiichi ;
Nobumoto, Atsuya ;
Tateno, Hiroaki ;
Watanabe, Kota ;
Niki, Toshiro ;
Katoh, Shigeki ;
Miyake, Minoru ;
Nagahata, Syun-Ichiro ;
Hirabayashi, Jun ;
Kuchroo, Vijay K. ;
Yamauchi, Akira ;
Hirashima, Mitsuomi .
JOURNAL OF IMMUNOLOGY, 2008, 181 (11) :7660-7669
[18]   TIM-1 and TIM-3 enhancement of Th2 cytokine poduction by mast cells [J].
Nakae, Susumu ;
Iikura, Motoyasu ;
Suto, Hajime ;
Akiba, Hisaya ;
Umetsu, Dale T. ;
DeKruyff, Rosemarie H. ;
Saito, Hirohisa ;
Galli, Stephen J. .
BLOOD, 2007, 110 (07) :2565-2568
[19]  
Ponath PD, 2000, METH MOL B, V138, P231
[20]   Th1-or Th2-cell commitment during infectious disease: an oversimplification? [J].
Rook, G .
TRENDS IN IMMUNOLOGY, 2001, 22 (09) :481-481